New targetable molecular abnormalities in AML - Hagop Kantarjian, MD

New targetable molecular abnormalities in AML - Hagop Kantarjian, MD

ScrippsHealth

4 years
359 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Hagop Kantarjian, MD of MD Anderson Cancer Center discusses the new targetable molecular abnormalities in AML at the Scripps 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
Up Next Autoplay